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in the chemical industry, and then inbio-
remediation, and finally in the personal
sewage treatment systems of today.
In 2023, the PSI-Genome Centers
were already designing organisms har-
boring proteins with exquisitely tuned
metabolic pathways. Organisms were
engineered with proteins designed to
operate in any environment and built-
in mechanisms to inhibit the spread of
their genes to naturally occurring spe-
cies. The ‘‘organisms and pathways
on demand’’ methods ultimately led to
the development of dual use carbon-
fixing microbes that are being used to
reduce atmospheric CO2 and to fuel
the new solar biocars that we all drive
today.
And here we are in 2030, in one of
the most optimistic times of human
history. Indeed even Toronto Maple
Leaf and Chicago Cubs fans are hope-
ful, certain that this will be the year they
finally win a championship.
Toronto. October 18, 2007
OK, so this is optimistic fantasy (or
maybe not). But the fact remains that
all the research on the ‘‘important’’
well-defined problems in biomedicine
have had less impact on human health
than have, for example, the poorly
characterized microbial communities
in sewage treatment plants. Similarly,
the microbes that live in our soil and
oceans, through their effects on the
planet’s climate and the elemental cy-
cles, are more central to our existence
than any medical treatment. If impact
on human health is a metric of impor-
tance, it is clearly important to study
problems outside what currently ap-
pears tobedirectly ‘‘relevant’’ to human
disease.
But therein lies the rub. We need to
understand the biome, or metage-
nome, but the questions are difficult
to define. How should one approach
such an ill-defined problem?
No one really knows, and this doubt-
less contributes to the angst about
funding structural and functional stud-
ies of the metagenome. And nowhere
is this angst felt more strongly than in
the structural biology community; the
holistic approach to science that
defines metagenomics is not in any
structural biologist’s ‘‘comfort zone.’’
Indeed, perhaps more than any other
branch of biomedical research, struc-
tural biology revels in precision and
accuracy and absolutism.
Yet the area is among the most im-
portant in modern science. So how
should structural biochemists get in-
volved? The genome sequencing and
annotation communities know full
well. There is a pressing need for ex-
perimental, protein-based annotation
of the new genes. Much as the won-
drous intricacies of DNA replication
and RNA transcription were revealed
through the efforts of structure-based
biochemistry and enzymology, uncov-
ering the innumerable mysteries of the
metagenome depend on similar ap-
proaches, only on a larger and more
integrated scale. All scientists, includ-
ing biochemists, enzymologists, and
structural biologists need to get with
the program.
Where to start? Again, it is impossi-
ble to say, but in our view the current
PSI aim to better define the protein
universe at a structural level is a good
first step. The natural next step for
the PSI is to forge closer links with
the genome sequencing centers in
a concerted effort to link sequence to
structure to function.
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three perspectives: (1) its impact on
science, (2) its policy implications,
and (3) its effects on funding structural
biology. In terms of its scientific im-
pact, I have some deep concerns,
chiefly related to the objectives and
the focus of the program, which
have, it appears to me, not been con-
sistent and clear. Initially, PSI had, I
vaguely recall, the stated purpose of
solving the structures comprising the1526 Structure 15, December 2007 ª200human proteome. Swiftly abandoning
that too ambitious idea, PSI was then
going to fill protein folding space with
carefully selected (by bioinformatics
miracles) gene products. This all
proved too demanding, so various or-
ganisms were chosen by different PSI
centers, and everyone started off in
all directions. Then some centers
dropped the idea entirely of solving
proteomes of anything and focused
on proteins that might serve the needs7 Elsevier Ltd All rights reservedof drug designers and pharmaceutical
development. Some turned to address
specific classes of enzymes, while
others continued to churn out what-
ever it was that crystallized. Any co-
herent theme vanished, and to this ob-
server, it has yet to be found again or
reconstructed. A major problem with
the current PSI is that its objectives
have become so scrambled that co-
herence has disappeared from the
program. Perhaps my vision is simply
Structure
Opinionsblurred, but that’s the picture I have of
it right now.
I am further concerned that I hear
increasingly that the greatest, or prin-
cipal benefits of PSI will be the tech-
nology development and technology
spin-offs. Now I appreciate new tech-
nology as much as anyone, but this
spin-off motive has a familiar and
ominous ring. I was a participant on
NASA advisory committees for nearly
15 years. The chief topic of mostmeet-
ings was the development of micro-
gravity and life science programs for
the US Space Station. Initially, NASA
announced that (what later became)
the International Space Station was
purely for science. It would be a plat-
form for science, and science would
be its sole objective. When that failed
to materialize, its continued impor-
tance rested on it serving as a vehicle
to inspire closer relations between
countries, principally the United States
and Russia. Then it was to be a plat-
form for the commercial development
of space, then a vehicle for inspiring
and educating America’s eager young
minds, and then a platform for the de-
velopment of engineering techniques.
Finally, NASA abandoned the pretense
that it was good for anything and justi-
fied its continued existence by touting
all the advanced technology spin-offs.
OK, call me a cynic, but the PSI is look-
ing more like a space station all the
time. When your major successes are
the spin-offs and not the stated objec-
tives, Houston, you have a problem.
One might conclude from this dark
vision that I favor abandoning PSI
completely—that would be wrong.
I believe that PSI could yet be an enor-mous success if it could just re-estab-
lish its focus, regain coherence and
purpose, redefine its objectives, and
get its act together. It could succeed
if it could make it evident to everyone
(well, no, you can never please every-
one) what the program was trying to
achieve and what progress it had
made in doing so.
The second and third perspectives,
policy and funding, are of course inter-
twined. It appears to this observer that
the NIH, by creating various kinds
of PSI mega- and minicenters, has
placed an excessive amount of other-
wise scarce resources in the hands of
a chosen few, and has somehow ex-
pected most of the worker bees out
there to cluster around the queens
and be productive. They have created
dukes and barons to oversee and dis-
pense the riches of the realm. This may
be good administrative logic, as I am
sure it is easier to manage a dozen or
so 20–50 million dollar projects than
tomanage several hundred smaller en-
terprises. But is it good science policy
to do that? Is it good funding policy?
Is the scientific return on the former
greater thanwould be that of the latter?
I’m afraid I have my misgivings.
The funding of R01 grants and other
grants to individual investigators by
NIH has fallen precipitously in recent
years, almost in parallel with the
growth of the PSI. Perhaps that is sim-
ply coincidence, but it is hard not to
draw the obvious conclusion that the
structural biology community is sacri-
ficing and suffering for the PSI. This
has produced the inevitable jealousies
and hard feelings among researchers.
They may have always been there,Structure 15, December 2007 ª2but hard times, which are what most
researchers are experiencing right
now, makes them more pronounced.
Perhaps PSI is getting a bad rap here.
Maybe PSI is actually a huge add-on
for structural biology, but if that is so,
it is not evident.
This has been a rather negative re-
view to this point, I realize. Were this a
study section review, PSI would be tri-
aged out on the first pass, no score, no
support, go away, and, indeed, I must
admit toacertaingloominess regarding
future prospects. That is unfortunate,
however, because the PSI does, in
fact, have some remarkable, and I think
unexpected achievements to boast
about. The PSI centers are currently
contributing a large portion of new
PDB entries, and a greater proportion
of their structures represent truly novel
structures and unique folds. By most
measures PSI structures appear to be
of greater precision and to contain
fewer errors than structures from out-
side thePSI.ThePSIstructuresarebet-
ter determined,Rfrees are lower, resolu-
tions higher, and costs lower. Quality
overall appears excellent and beyond
most observers expectations. New
technologies are indeed emerging by
the day—technologies that will be
broadly useful. The centers have been
conscientious in reporting structures
and allowing access, they have been
open with their operations, and willing
to share expertise and technology,
and onewould be hard-pressed to crit-
icize the commitment and honest effort
of the scientists involved in PSI re-
search. I wish my lab worked as well,
but then, I also wish my lab had their
funding.007 Elsevier Ltd All rights reserved 1527
